Table I.
Demographic and baseline characteristics (AT population)
| Characteristic | Children | Adolescents | Adults |
|---|---|---|---|
| 2–11 years | 12–15 years | 16–64 years | |
| N = 18 | N = 5 | N = 28 | |
| Gender, n (%) | |||
| Female | 5 (27.8) | 0 (0) | 11 (39.3) |
| Male | 13 (72.2) | 5 (100) | 17 (60.7) |
| Age (years) | |||
| Mean (SD) | 7.2 (2.5) | 14.0 (1.0) | 34.1 (12.7) |
| Median (Range) | 7.5 (3–11) | 14.0 (13–15) | 32.5 (16–60) |
| Weight (kg) | |||
| Mean (SD) | 25.9 (11.06) | 57.1 (15.84) | 69.2 (13.34) |
| Median (Range) | 22.0 (13–56) | 53.3 (36–77) | 70.2 (41–96) |
| BMI (kg/m2) | |||
| Mean (SD) | 16.4 (2.88) | 20.6 (2.29) | 23.3 (3.96) |
| Median (Range) | 15.3 (12–24) | 20.1 (18–23) | 23.0 (16–32) |
| Primary disease | |||
| CVID, n (%) | 7 (38.9) | 0 (0) | 23 (82.1) |
| XLA, n (%) | 10 (55.6) | 5 (100) | 5 (17.9) |
| ARAG, n (%) | 1 (5.6) | 0 (0) | 0 (0) |
AT all treated (23 pediatric patients), N number of patients in age group, SD standard deviation, CVID common variable immunodeficiency, XLA X-linked agammaglobulinemia, ARAG autosomal recessive agammaglobulinemia